Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed enrollment with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

Sponsor: NRG Oncology | Conditions: Breast Carcinoma, Cervical Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-03-08